28/02/24 Research Charcot Marie Tooth Pharnext progresses in analyzing data from pivotal Phase III study ofPXT3003 in Charcot-Marie-Tooth disease type 1A Continue Reading
15/01/24 Research Charcot Marie Tooth CMT Research Database Can you help with Charcot-Marie-Tooth clinical research? If you have Charcot-Marie-Tooth disease, live in the United Kingdomand would like to […] Continue Reading
20/12/23 Research Charcot Marie Tooth Pharnext reports topline results from the pivotal Phase III clinical trial(PREMIER trial) of PXT3003 in Charcot-Marie-Tooth disease type 1A Continue Reading
20/12/23 Research Charcot Marie Tooth Pharnext intends to prepare registration and marketing authorizationdossiers for PXT3003, its drug candidate in Charcot-Marie-Tooth diseasetype 1A Continue Reading
20/09/23 Research Charcot Marie Tooth Pharnext enters the final stretch for the signature of a licensingagreement for its drug candidate in Charcot-Marie-Tooth disease type 1A(PXT3003), enabling it to capitalize on its assets and put an end to theOCEANE-BSA financing line Continue Reading
